SCHEMBL22397228

SCHEMBL22397228

Cc1ncc(-c2ccc3nc(NCC(C)(C)C#N)cn3n2)cc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22397190 0.91 RIPK1 (0.50) RIPK1
SCHEMBL22397196 0.89 RIPK1 (0.53) RIPK1
SCHEMBL22371316 0.84 RIPK1 (0.67) RIPK1
SCHEMBL22397188 0.84 RIPK1 (0.54) RIPK1
SCHEMBL30468332 0.80 RIPK1 (0.66) RIPK1
SCHEMBL22371004 0.80 RIPK1 (0.66) RIPK1
SCHEMBL22397187 0.77 RIPK1 (0.53) RIPK1
Lithium Ion SCHEMBL29849297 0.77 RIPK1 (0.65) RIPK1
SCHEMBL22371304 0.77 RIPK1 (0.64) RIPK1
SCHEMBL22370942 0.73 RIPK1 (0.67) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704118-A1 AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2020-09-09 EP disclosed